Biotech - SiliconSnark

SiliconSnark robot guides droplets across a laboratory chip on Cambridge’s Main Street, with MIT in the distance.

Boston Tech

DropGenie’s $5 Million Round Puts Cambridge’s Lab Ambitions on Droplet Rations

DropGenie’s $5 million Seed+ round backs miniature gene-editing workflows in Cambridge and Montréal, with promising lab evidence and a 2027 rollout ahead.

SiliconSnark robot packs molecular tools into a delivery capsule in a Cambridge lab overlooking the Charles River.

Boston Tech

Arbor Biotechnologies Advances Three ALS Candidates, With Molecular Carry-On Luggage

Cambridge’s Arbor Biotechnologies advances three ALS gene-editing candidates, targeting brain delivery and 2027 filings. A serious bet, still preclinical.

SiliconSnark robot operates a microscope beside glowing cell images in a Needham laboratory.

Boston Tech

Evident Buys CrestOptics to Give Biology Better Lighting and Fewer Excuses

Evident acquired CrestOptics on October 5, expanding live-cell microscopy. Its Needham operation links Boston biotech to a global scientific tools deal.

SiliconSnark robot prints employee badges beside Massachusetts lab and medical-device manufacturing scenes.

Boston Tech

Massachusetts Puts Nearly $40 Million Behind Biotech’s Most Radical Product, a Payroll

Massachusetts announced nearly $40 million in life-sciences tax incentives tied to 1,644 jobs, backing Insulet, Lila Sciences and statewide expansion.

SiliconSnark robot offers an AI trophy to a lab sample while a scientist checks experimental results.

Anthropic Built a Biology Lab. The Petri Dish Gets a Veto.

Anthropic has a physical biology lab. Real experiments could sharpen its AI science ambitions, but a lab coat is not evidence of a cure.

SiliconSnark robot juggles a notebook, laptop, and iced coffee in an imagined Cambridge AI office.

Boston Tech

Anthropic’s Boston Office Could Tackle Science, Software, and the Final Boss: Dunkin’

What could Anthropic work on in its Boston office? A snarky look at science, software, and AI safety—with plausible ideas clearly separated from confirmed plans.

SiliconSnark robot welcomes an AI office to Kendall Square as scientists inspect research methods around a conference table.

Boston Tech

Anthropic Expands in Boston. Kendall Square Would Like to See the Methods Section.

Anthropic’s Cambridge expansion gives Boston’s innovation economy a timely opening. The payoff depends on research, local startups, and more than office space.

SiliconSnark robot examines six aging clocks and a glass lung model in a Cambridge laboratory.

Boston Tech

Insilico’s Rentosertib Made Six Aging Clocks Blink. Boston Would Like the Receipts.

Insilico’s rentosertib study links an AI-designed lung drug to lower aging-clock estimates, with Boston researchers and important limits on the findings.

SiliconSnark robot routes MC4R signals through a switchboard in a Boston biotech lab.

Boston Tech

Superluminal Medicines Raised $60 Million to Make an Appetite Switch Pick a Lane

Boston biotech Superluminal Medicines raised $60 million to take an AI-designed oral drug for rare genetic obesity into its first human trial.

SiliconSnark robot replays sensor data from a laboratory experiment in Cambridge.

Boston Tech

Transfyr Raised $25 Million to Give Lab Experiments a Replay Button

Cambridge startup Transfyr raised $25 million to turn lab work into machine-readable data for reproducibility, training, and scientific automation.

Startups

Five Maine Tech Startups You Haven’t Heard Of. Fish Blood Is Involved.

Meet five Maine tech startups building industrial software, smart energy plugs, fish-blood biotech, seaweed plastics and water-monitoring buoys.

SiliconSnark robot studies a personalized mRNA cancer treatment in a Cambridge lab.

Boston Tech

Moderna’s Cancer Vaccine Finally Got Its Big Phase 3 Moment. The Footnotes Are Still in Cambridge.

Moderna and Merck say their personalized mRNA cancer vaccine met Phase 3 melanoma endpoints. The Cambridge biotech has a real win, with caveats.

See all